Review Article
Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease
Table 1
PPARs expression and respective ligands.
| | Types | Major distribution | Targets |
| | Agonist |
| | PPARα | Liver, heart, kidney | Fenofibrate | | Clofibrate | | (FGF21) | | (G0S2) |
| | PPARβ/δ | Skeletal muscle, liver | GW0742 | | GW501516 | | MBX-8025 |
| | PPARγ | Adipose tissue | TZDs | | (rosiglitazone, pioglitazone) | | Palmitate | | PGC1 |
| | PPARα/δ | | GFT505 (elafibranor) |
| | PPARα/γ | | Tesaglitazar | | | Glitazars (saroglitazar) |
| | Antagonist |
| | PPARγ | | Isorhamnetin (quercetin) |
| | PPARα/γ | | Z-551 |
|
|